Immediate Impact
45 standout
Citing Papers
Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia
2024 Standout
Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy
2023 Standout
Works of M. Debelle being referenced
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| M. Debelle | 298 | 70 | 11 | 82 | 76 | 13 | 362 | |
| Judit Harsányi | 303 | 86 | 4 | 85 | 68 | 15 | 390 | |
| Enrico Smeraldi | 239 | 64 | 13 | 92 | 79 | 12 | 375 | |
| L. Potter | 248 | 68 | 23 | 60 | 101 | 15 | 411 | |
| Kenneth Greenspan | 194 | 64 | 26 | 95 | 58 | 10 | 341 | |
| LEON J. HEKIMIAN | 273 | 73 | 47 | 73 | 64 | 14 | 399 | |
| C. A. Gagiano | 239 | 46 | 14 | 57 | 144 | 18 | 372 | |
| Maria Abate | 235 | 90 | 2 | 68 | 121 | 14 | 404 | |
| J.-P. Boulenger | 174 | 76 | 6 | 156 | 40 | 13 | 364 | |
| J. Andersen | 203 | 80 | 5 | 44 | 115 | 16 | 361 | |
| Д. Набер | 246 | 81 | 16 | 70 | 39 | 26 | 390 |
All Works
Loading papers...